Drug intelligence / Profile preview

trimecaine

Development stage
Phase 2
Lead developer
Spofa
Modality
Small Molecules
Administration
Intravenous, Subcutaneous, Topical, Intramuscular, Intrathecal, Intranasal
01

Overview

Trimecaine is a local anesthetic of the amide group and a Class Ib antiarrhythmic agent, primarily developed and utilized in Central and Eastern Europe (notably the former Czechoslovakia). As a derivative of lidocaine, it functions by reversibly blocking voltage-gated sodium channels in neuronal membranes, thereby inhibiting the initiation and conduction of nerve impulses to provide regional anesthesia. In cardiology, trimecaine is used to treat and prevent ventricular arrhythmias, particularly those occurring in the setting of acute myocardial infarction, by shortening the action potential duration and effective refractory period in Purkinje fibers. It is characterized by a rapid onset of action and is administered via various routes including infiltration, topical, and intravenous injection.

Brand names
Mesocain
Other names
MesocainumMesokainTrimecaine hydrochloride2-(diethylamino)-N-(2,4,6-trimethylphenyl)acetamide
02

Targets

NaV (Voltage-gated sodium channels)

Beyond the preview

Go deeper on trimecaine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on trimecaine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call